CNBC Television published this video item, entitled “Cue Health CEO on FDA emergency authorization for Covid at-home test” – below is their description.
The FDA has granted emergency use authorization for Cue Health’s rapid Covid test, making it the first molecular test for Covid-19 authorized for at-home use without a prescription. Ayub Khattak, Cue Health co-founder and CEO, joined “Squawk Box” on Monday to discuss.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.